Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wittes

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
American Journal of Epidemiology|October 1, 1975
Spontaneous abortion as a screening device. The effect of fetal survival on the incidence of birth defectsZ Stein, M Susser, D Warburton, et al.
Journal of Clinical Epidemiology|July 3, 1999
Simultaneous screening for three correlated lipids in the VA HDL Intervention TrialM K Iwane, J Wittes, D E Collins, et al.
Controlled Clinical Trials|June 1, 1988
In memoriam: Max Halperin (1917-1988)J Lachin, T Gordon, S Greenhouse, et al.
Controlled Clinical Trials|May 5, 1999
Selecting screening criteria for clinical trials: an example from the Systolic Hypertension in the Elderly ProgramJ Wittes, E Lakatos, D Black, et al.
European Heart Journal|March 1, 1992
Preserved left ventricular function during supine exercise in patients after orthotopic cardiac transplantationK K Teo, S Yusuf, J Wittes, et al.
Circulation|April 1, 1987
Increased sensitivity of the denervated transplanted human heart to isoprenaline both before and after beta-adrenergic blockadeS Yusuf, S Theodoropoulos, C J Mathias, et al.
The American Journal of Cardiology|September 15, 1989
Influence of beta blockade on exercise capacity and heart rate response after human orthotopic and heterotopic cardiac transplantationS Yusuf, S Theodoropoulos, N Dhalla, et al.
The New England Journal of Medicine|September 2, 1999
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study InvestigatorsB Pitt, F Zannad, W J Remme, et al.
Controlled Clinical Trials|December 1, 1996
Approached to monitoring the results of long-term disease prevention trials: examples from the Women's Health InitiativeL Freedman, G Anderson, V Kipnis, et al.
The American Journal of Clinical Nutrition|April 1, 1994
Dietary trans fatty acids: effects on plasma lipids and lipoproteins of healthy men and womenJ T Judd, B A Clevidence, R A Muesing, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
American Journal of Epidemiology|October 1, 1975
Spontaneous abortion as a screening device. The effect of fetal survival on the incidence of birth defectsZ Stein, M Susser, D Warburton, et al.
Journal of Clinical Epidemiology|July 3, 1999
Simultaneous screening for three correlated lipids in the VA HDL Intervention TrialM K Iwane, J Wittes, D E Collins, et al.
Controlled Clinical Trials|June 1, 1988
In memoriam: Max Halperin (1917-1988)J Lachin, T Gordon, S Greenhouse, et al.
Controlled Clinical Trials|May 5, 1999
Selecting screening criteria for clinical trials: an example from the Systolic Hypertension in the Elderly ProgramJ Wittes, E Lakatos, D Black, et al.
European Heart Journal|March 1, 1992
Preserved left ventricular function during supine exercise in patients after orthotopic cardiac transplantationK K Teo, S Yusuf, J Wittes, et al.
Circulation|April 1, 1987
Increased sensitivity of the denervated transplanted human heart to isoprenaline both before and after beta-adrenergic blockadeS Yusuf, S Theodoropoulos, C J Mathias, et al.
The American Journal of Cardiology|September 15, 1989
Influence of beta blockade on exercise capacity and heart rate response after human orthotopic and heterotopic cardiac transplantationS Yusuf, S Theodoropoulos, N Dhalla, et al.
The New England Journal of Medicine|September 2, 1999
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study InvestigatorsB Pitt, F Zannad, W J Remme, et al.
Controlled Clinical Trials|December 1, 1996
Approached to monitoring the results of long-term disease prevention trials: examples from the Women's Health InitiativeL Freedman, G Anderson, V Kipnis, et al.
The American Journal of Clinical Nutrition|April 1, 1994
Dietary trans fatty acids: effects on plasma lipids and lipoproteins of healthy men and womenJ T Judd, B A Clevidence, R A Muesing, et al.
Pageof 6